Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Intrathecal + IV nivo for metastatic melanoma with leptomeningeal disease

Sunandana Chandra, MD, MS, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, reviews data from a single-center Phase I/Ib study of concurrent intrathecal and intravenous nivolumab for patients with metastatic melanoma with leptomeningeal disease. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).